/
We are a development-stage medical device company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Our first-in-class technology platform includes a catheter-based microchip-enabled sensing array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
ROIC dropped from -109.44% to -192.32%, capital efficiency is deteriorating. Negative free cash flow of -$12M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$0.00
Net Income (TTM)
-$17M
▼ -46.5% YoY
Op. Margin
—
ROIC
-192.32%
▼ -82.9pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$12M
▼ -48.6% YoY
Op. Cash Flow (TTM)
-$12M
▼ -48.7% YoY
Net Debt
-$7M
Net Cash Position
Cash & Equiv.
$7M
Continue Research